科创创新药ETF（589720）大涨5%，指数跑赢主要港股创新药指数

Group 1 - The pharmaceutical sector is experiencing a strong rebound, with the Guotai Innovation Drug ETF (589720) rising by 5% [1] - The fundamentals of innovative drugs remain positive, with significant therapeutic products showing a trend of increasing volume based on mid-year performance disclosures [1] - Upcoming academic conferences, including the WCLC from September 6 to September 9 and ESMO from October 17 to October 21, are expected to catalyze the market with excellent data releases [1] Group 2 - The domestic innovative drug industry has been building momentum for ten years and is currently entering a phase where innovative results are being realized [1] - The Guotai Innovation Drug ETF focuses on innovative drug companies listed on the Sci-Tech Innovation Board, tracking 30 representative high-quality companies [1] - Since the "924 market" last year, the Sci-Tech Innovation Drug Index has outperformed major Hong Kong innovative drug indices, with returns of 125.97%, 121.81%, and 116.32% for the Sci-Tech Innovation Drug, Hong Kong Innovative Drug, and Hang Seng Hong Kong Stock Connect Innovative Drug Indices, respectively, during the market rebound period from September 24, 2024, to August 31, 2025 [1]